8/8/2023

Methylprednisolone Acetate Injection

Reason for the Shortage

- Amneal has methylprednisolone acetate injection available.[1]
- Eugia has methylprednisolone acetate injection available.[2]
- Pfizer has Depo-Medrol available. This product was not affected by the tornado in Rocky Mount.[3]
- Sagent has methylprednisolone acetate injection available.[4]
- Teva is not currently marketing methylprednisolone acetate.[5]

Available Products

- Depo-Medrol injection, Pfizer, 20 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00009-0274-01
- Depo-Medrol injection, Pfizer, 40 mg/mL, 1 mL single dose vial, 1 count, NDC 00009-3073-01
- Depo-Medrol injection, Pfizer, 40 mg/mL, 1 mL single dose vial, 25 count, NDC 00009-3073-03
- Depo-Medrol injection, Pfizer, 40 mg/mL, 10 mL multiple dose vial, 1 count, NDC 00009-0280-03
- Depo-Medrol injection, Pfizer, 40 mg/mL, 10 mL multiple dose vial, 25 count, NDC 00009-0280-52
- Depo-Medrol injection, Pfizer, 40 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00009-0280-02
- Depo-Medrol injection, Pfizer, 40 mg/mL, 5 mL multiple dose vial, 25 count, NDC 00009-0280-51
- Depo-Medrol injection, Pfizer, 80 mg/mL, 1 mL single dose vial, 1 count, NDC 00009-3475-01
- Depo-Medrol injection, Pfizer, 80 mg/mL, 1 mL single dose vial, 25 count, NDC 00009-3475-03
- Depo-Medrol injection, Pfizer, 80 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00009-0306-02
- Depo-Medrol injection, Pfizer, 80 mg/mL, 5 mL multiple dose vial, 25 count, NDC 00009-0306-12
- Methylprednisolone Acetate injection, Amneal, 40 mg/mL, 1 mL single dose vial, 1 count, NDC 70121-1573-01
- Methylprednisolone Acetate injection, Amneal, 40 mg/mL, 1 mL single dose vial, 25 count, NDC 70121-1573-05
- Methylprednisolone Acetate injection, Amneal, 80 mg/mL, 1 mL single dose vial, 1 count, NDC 70121-1574-01
- Methylprednisolone Acetate injection, Amneal, 80 mg/mL, 1 mL single dose vial, 25 count, NDC 70121-1574-05
- Methylprednisolone Acetate injection, Eugia US, 40 mg/mL, 10 mL multiple dose vial, 1 count, NDC 55150-0313-01
- Methylprednisolone Acetate injection, Eugia US, 80 mg/mL, 5 mL multiple dose vial, 1 count, NDC 55150-0314-01
- Methylprednisolone Acetate injection, Sagent, 40 mg/mL, 10 mL multiple dose vial, 1 count, NDC 25021-0820-10
- Methylprednisolone Acetate injection, Sagent, 40 mg/mL, 5 mL multiple dose vial, 1 count, NDC 25021-0820-05
- Methylprednisolone Acetate injection, Sagent, 80 mg/mL, 5 mL multiple dose vial, 1 count, NDC 25021-0821-05

Estimated Resupply Dates

- All currently marketed presentations are available.

Alternative Agents & Management

The table below lists possible alternatives for patients who receive injectable corticosteroid suspensions.

Table 1. Alternative agents for disorders commonly treated injectable corticosteroid suspensions.6-7
Intra-articular injections for disorders such as rheumatoid arthritis and bursitis	Betamethasone acetate/betamethasone sodium phosphate
Intralesional injections	Triamcinolone acetonide <40 mg per treatment Methylprednisolone acetate 20 to 40 mg per treatment for large lesions

References

1. Amneal (personal communication). August 20, and December 16 and 17, 2021, August 26, 2022; February 23, and July 7, 2023.
2. Eugia (personal communication. June 28, and August 4, 2023.
3. Pfizer (personal communication). August 20, September 17, November 19, December 10, 2021, and July 1, August 26, 2022; March 10, April 7, and August 4, 2023.
4. Sagent (personal communication. July 22, August 26, 2022; March 9, April 6, and August 3, 2023.
5. Teva (personal communication). August 20, September 17, November 12, December 10, 2021, July 1, August 26, 2022; March 10, and April 7, 2023.
6. Lexicomp Online. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc; 2018.
7. Dexamethasone sodium phosphate injection [package insert]. Lake Zurich, IL: Fresenius Kabi; 2021.

Updated

Updated August 8, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 20, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.